APA

Céruse P., Cosmidis A., Belot A., Rabilloud M., Fuchsmann C., Poupart M., Ramade A., Tartas S., Favrel V., Pommier P., Zrounba P. & Fayette J. (20150512). A pyriform sinus cancer organ preservation strategy comprising induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil, followed by potentiated radiotherapy: a multicenter, retrospective study. : Anti-cancer drugs.

Chicago

Céruse Philippe, Cosmidis Alain, Belot Aurélien, Rabilloud Muriel, Fuchsmann Carine, Poupart Marc, Ramade Antoine, Tartas Sophie, Favrel Véronique, Pommier Pascal, Zrounba Philippe and Fayette Jérôme. 20150512. A pyriform sinus cancer organ preservation strategy comprising induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil, followed by potentiated radiotherapy: a multicenter, retrospective study. : Anti-cancer drugs.

Harvard

Céruse P., Cosmidis A., Belot A., Rabilloud M., Fuchsmann C., Poupart M., Ramade A., Tartas S., Favrel V., Pommier P., Zrounba P. and Fayette J. (20150512). A pyriform sinus cancer organ preservation strategy comprising induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil, followed by potentiated radiotherapy: a multicenter, retrospective study. : Anti-cancer drugs.

MLA

Céruse Philippe, Cosmidis Alain, Belot Aurélien, Rabilloud Muriel, Fuchsmann Carine, Poupart Marc, Ramade Antoine, Tartas Sophie, Favrel Véronique, Pommier Pascal, Zrounba Philippe and Fayette Jérôme. A pyriform sinus cancer organ preservation strategy comprising induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil, followed by potentiated radiotherapy: a multicenter, retrospective study. : Anti-cancer drugs. 20150512.